Pneumonia has been described in medical texts for centuries: as early as the fourth century BC Hippocrates first recorded the use of auscultation in pneumonia and described the friction rub of pleurisy 1 . It used to be the most common cause of death, killing about 200 persons per 100,000 per year in the U.S.A. at the turn of the century 2 . The introduction of antibiotics in the 1940s, decreased the mortality to about 70 per 100,000 per year 3 . The study by Austrian and Gold in 1964 , which reported a case fatality rate of 25% in a series of 455 patients with bacteraemic pneumonia 4 , indicated that antibiotic therapy was not the complete solution. The next attempt to reduce mortality involved application of life-supporting therapies in intensive care units (ICUs) 5 . It was estimated that between two and 15 people per 1000 per year in various populations suffered from community-acquired pneumonia 3 , and out of the 20% to 40% of patients who had to be hospitalized [6] [7] [8] , 5% to 36% were managed in ICUs [9] [10] [11] [12] [13] . Several studies [14] [15] [16] in the early 1980s however, indicated that the mortality of patients with severe community-acquired pneumonia was as high as 47 to 76% despite intensive care, and it was questioned whether such patients should be admitted into ICU 17 . This review examines the outcome of patients suffering from severe communityacquired pneumonia and the possible strategies to improve patient outcome.
DEFINITIONS
Pneumonia has been defined as an inflammatory process of the pulmonary parenchyma produced by micro-organisms 18 . However, it is more practical to define it clinically as an acute septic episode with res-piratory symptoms and radiologic shadowing which was neither pre-existing nor of other known cause 11, [19] [20] [21] . The operational definition used in various studies shows significant variation 13 , but it was most commonly diagnosed by 1. the presence of a new radiographic pulmonary infiltrate, and 2. acute onset of at least one "major" or two "minor" clinical findings suggestive of pneumonia 11, [22] [23] [24] . The "major" criteria were cough, sputum production and fever. The "minor" criteria were dyspnoea, pleuritic chest pain, altered mental status, pulmonary consolidation by physical examination and a total leucocyte count over 12000/mm 3 .
Community-acquired infection is defined as an infection that occurs in a patient who has not been hospitalized in the preceding two weeks, or one that occurred within 48 hours of admission to hospital 11, 13, [25] [26] [27] . Some series included patients admitted from nursing homes 13, 22 and/or patients who were immunocompromised 9, 15, 22, 28 . CAP in these patients differs from the rest in microbial aetiology, clinical features, and outcome 13, 29 but these will not be addressed specifically in this review.
The term severe community-acquired pneumonia (SCAP), although commonly used, has not been precisely defined. It is usually taken to mean community-acquired pneumonia (CAP) severe enough to require management in ICU. In practice, patients were admitted into ICU because of an unstable condition requiring specialized medical and nursing care and this may include immediate or potential requirement for mechanical ventilatory support, the presence of septic shock, altered consciousness, and/or extrapulmonary complications of pneumonia such as endocarditis 10, 15, 19, 20, 22, [30] [31] [32] . SCAP has also been defined as CAP associated with a SAPS score of 8 or above 19 . The lack of a uniform definition of SCAP partly explains the difference in mortality reported by different authors. It is hoped that the criteria suggested by the American Thoracic Society 29 
and/or the INTO INTENSIVE CARE UNIT The Value of Intensive Care
As mentioned above, it has been suggested that death from pneumonia is predetermined and that intensive care merely prolongs the interval before death 4, 17 . Nonetheless, Rogers et al 5 have concluded over two decades ago that there was a dramatic reduction in mortality from acute respiratory failure, including patients with pneumonia, when these patients were treated in a respiratory care unit. and this was subsequently supported by other studies 40, 41 . The findings of all large series of SCAP showed that over 50% of patients requiring mechanical ventilatory support and around 40% of patients in septic shock will survive 8, 9, 11, 12, 14, 15, 19, 20, 22, 28, 30, 33, 35, 42 .
Identification of High Risk Patients
Although not scientifically proven 3 , it is widely believed that early identification of patients with SCAP and early admission to ICU may improve patient outcome 19, 31, 33, 34 . To achieve this a sensitive and reasonably reliable system for the identification of high risk patients is required. There are two possible approaches: use a non-specific severity scoring system or devise a system specific for CAP.
Non-Specific Severity Scoring Systems
Scoring systems such as the Simplified Acute Physiology Score (SAPS) 43 , Acute Physiological Score (APS) 44 , and the APACHE II Score 45 have been used by several authors to measure the severity of CAP and it has been found that SAPS of >13 or APACHE II of >20 on admission are associated with higher mortality 14, 15, 19, 28 . The APS and SAPS have also been found by Durocher et al 46 to correlate well with a specific scoring system for pneumonia developed by themselves. The non-specific scoring systems have been criticized for not including important prognostic factors for SCAP and because they usually underestimate the severity of CAP 14, 15 .
CAP-Specific Prediction Systems
Univariate and multivariate analyses have identified a number of specific prognostic factors for CAP.
Univariate Analysis Patient related factors
Age. The mortality of patients aged 60 or over is approximately twice that of younger patients 3, 13, 16, 19, 22, 30, 32, 35, 38, 47, 48 . Age per se, however, may not be an independent factor 22 but only generate its effect through association with underlying diseases and/or degeneration of organ function. Patients should not be denied ICU admission on the ground of age alone and other factors must be considered. Indeed, earlier ICU admission of elderly patients should be considered because of their higher risk.
Sex. While male patients may be more likely to die from SCAP than female patients, this fact should have little practical relevance in decision making 3, 13, 49 . 22 (1994) 19 (1994) 28 (1993) 120 (1992) 33 (1991) 11 (1990) 12 (1990) 32 (1989) 9 (1989) 14 (1988) 15 (1986) 8 (1985) 35 (1985) 30 (1983) 16 Alcoholism. Alcoholism, defined as daily consumption of alcohol of 80g or more at least during the recent two years, has a significant effect on the lungs and is associated with a markedly increased mortality rate 3, 11, 38, [50] [51] [52] [53] [54] . Alcohol may affect the lungs through depression of ciliary function, inhibition of surfactant production, retardation of migration of neutrophils in the lung, impairment of activity of macrophages and reduction of lung volumes. Alcoholics are also more likely to be suffering from poor nutrition, aspiration pneumonitis, excessive smoking and alcoholic liver cirrhosis [50] [51] [52] [53] [54] . Mortality rate in alcoholics with Klebsiella pneumonia has been reported to be 50-65% and approaching 100% in the presence of bacteraemia [50] [51] [52] .
Chronic Lung Diseases. About one-third or more of patients in most studies had chronic lung diseases such as COAD as an underlying condition 9, 11, 19, 20, 22 . The co-existence of chronic respiratory insufficiency however, is not associated with a significantly higher mortality 11, 22 and as such these patients should not be denied ICU admission.
Other Underlying Conditions. Despite findings to the contrary 19 , patients with a serious underlying condition such as cancer or stroke 13 or other debilitating diseases including conditions which are ultimately fatal or rapidly fatal as defined by McCabe and Jackson 55 have a significantly higher mortality 11, 22, 28, 30, 32, 49 .
Immunodeficiency. Immunodeficiency or immunosuppression is also significantly associated with higher mortality. The microorganisms responsible for pneumonia in such patients are also different from other patients 22 .
Disease-related factors
Bacteraemia. The mortality rate of patients who are bacteraemic, defined as the isolation of an organism capable of producing pneumonia from blood culture 11, 20 , is about three times of those patients with negative blood cultures 11, 14, 19, 22, 47, 50, 56 .
Septic Shock. Septic shock is one of the most powerful predictors of poor outcome. The mortality of patients who develop septic shock is more than twice that of other patients 11, 16, 19, 20, 22, 28, 32, 49, 56 .
Mechanical Ventilation Requirement. Almost all series show that patients requiring mechanical ventilatory support have a higher mortality rate, which may be more than twice those not ventilated 11, 22, 19, 28, 30, 35, 49, 57 .
Hypoxaemia. The significance of hypoxaemia is not as clear-cut 15, 19 , but on the whole it seems that patients who are hypoxaemic or require a high FiO 2 and PEEP to maintain oxygenation are more likely to die 11,30,42,49 56 .
Respiratory Rate. A respiratory rate of 30/min or higher is significantly associated with mortality 11, 15, 21, 33 , and in one series it was found that all patients with respiratory rate of 45/min or more died 15 . This correlation is not unexpected, as tachypnoea occurs as the respiratory system adjusts to the presence of local inflammation, hypercapnia, acidosis, and hypoxaemia 21 .
Impaired Alertness. This has also been found to be associated with increased mortality 15, 19, 28, 32, 34, 47 .
Temperature. Patients who were afebrile may be severely ill and in some studies had a higher mortality 13, 23, 58 .
Leucocyte and Platelet Count. With few exceptions 19 , a lack of leucocytosis (with a white cell count of less than 3.5-4.0 x 10 9 /l) and a low platelet count (<150 x 10 9 /l) have been associated with a higher mortality rate 3, 14, 22 . The lack of leucocytosis has been attributed to either peripheral sequestration of white cells within visceral capillaries or to poor bone marrow reserve and folate deficiency which is common amongst alcoholics. Thrombocytopenia may be an early indicator of consumptive coagulopathy 14 .
Hypoalbuminaemia. A low serum albumin level (less than 30 g/l) also correlates with poor outcome 14, 15, 22, 28 . Low albumin may not only reflect poor nutritional status and thus poor resistance, but may also be the result of increased interleukin-1 associated with severe sepsis 59, 60 .
Other Biochemical Findings. Raised serum creatinine and/or urea 14, 15, 21, 22, 28, 30, 33, 49, 56 and high serum phosphate level 14 , indicating renal dysfunction, also correlate with poor outcome. Metabolic acidosis is also a poor prognostic factor 47, 49 , representing the effects of severe infection and impaired tissue perfusion 21 . The association of increased LDH, CK, and CK-MB level with higher mortality was also established in one study 56 .
Radiological Features. With few exceptions 15, 19 , most studies found that multilobe consolidation and radiologic evidence of spread of pneumonia indicate severe disease and poor outcome 11, 22, 49, 56 .
Microbiologic Diagnosis. Pneumococci, Gram negative bacilli, and S. aureus are associated with higher mortality. Legionella and M. pneumoniae, on the other hand, were associated with better prognosis 6, 11, 14, 19, 20, 21, 34, 35, 47, 59 .
Multivariate Analysis, Scoring Systems & Guidelines
In the last 15 years, several authors 11, 13, 15, 19, 22, 29, 34, 46 have attempted to delineate factors which indepen-dently predicted mortality, and/or to combine all of these factors together to devise a scoring system. The applicability of the findings of Leroy et al 22 24, 60 for early selection of patients for intensive care admission is limited, as some of the information required is not available early in the course of the disease. The scoring system of Durocher et al 46 is rather complicated; it was devised for the purpose of comparison of outcome rather than for early identification of patients at risk 46 . While the scoring system of van Eeden et al 15 is simpler and designed for this purpose, the study from which the information was derived included only a small group of patients and the value of the system was unproven. The British Thoracic Society 34 guidelines ( Table 2 ) are simple and reliable, and represent the only multivariate analysis which has been subsequently validated by two other studies 21, 33 . The guidelines recommended by the American Thoracic Society 29 (Table 3) , though not scientifically proven, summarize the high risk factors identified by various studies.
ADEQUATE ANTIMICROBIAL THERAPY
Failure to administer effective antimicrobial therapy promptly has been found to be associated with increased mortality, which may be as much as six times greater than for patients given effective antibiotics 11, 22, 34 . Empirical antimicrobial therapy should be selected according to information regarding the most likely aetiological agent, and based on epidemiological data, clinical and laboratory parameters.
Epidemiological Data
Before the advent of antibiotic therapy, lobar pneumonia was almost always caused by pneumococci 61 . Nowadays, the aetiology is more variable and differs from study to study. This difference in aetiology amongst various studies may be related to differences in 1. methodology of the bacteriologic study; 2. local epidemiology of the area where the study is performed; and 3. proportion of patients with predisposing factors 22 .
S.pneumoniae remains the most frequent causative agent, accounting for about one third of patients. This may be underestimated partly because of prior antimicrobial therapy, and many cases of negative bacteriology may actually be caused by pneumococci 19, 26, 34, 62 . It is reasonable to assume pneumococcus to be the agent causing SCAP in most young patients without underlying disease. Penicillin-resistant strains In addition, an increase in the size of the opacity by 50% or greater within 48h of admission is indicative of severe pneumonia. 5. Shock (systolic blood pressure below 90 mmHg or diastolic blood pressure below 60 mmHg). 6. Requirement for vasopressors for more than 4h. 7. Urine output lower than 20 ml/h, or total urine output lower than 80 ml in 4h, unless another explanation is available, or acute renal failure requiring dialysis.
of pneumococci have been isolated in Spain, Hungary and Canada and multiple resistant pneumococci have been found in South Africa and Europe 31, 63 . Pneumococcus, however, is usually covered effectively by penicillin, ampicillin, erythromycin, or the third generation cephalosporins. Agents causing "Atypical Pneumonia" (Legionella pneumophila, M. pneumoniae, or C. pneumoniae). M. pneumoniae and C. pneumoniae are responsible for 3% or less of SCAP in most series although more frequent in CAP outside ICU 13 . This is because the outcome of pneumonia caused by such agents is usually favourable and rarely necessitates intensive care 11, 19, 22, 32 . The incidence of Legionella sp., on the other hand, varies according to area: it is the most frequent aetiology after S. pneumoniae in Spain 11, 20, 32 and U.S.A. 23 , lower in Great Britain 13, 34, 39, 60 and Sweden 9 , and very low in France 19, 22 , South Africa 14, 15 and Australia 26 . It is important to cover legionella with a macrolide antibiotic in regions where its incidence is high (Table 4) .
Enterobacteriaceae, especially E. coli and Klebsiella pneumoniae, account for about 15-25% of patients in some South African, American and French series, but much less frequent in British, Swedish, and Australian studies 26 . This is higher than the usually quoted incidence of 3-11% in textbooks 18 and may be explained by the fact that pneumonia caused by these agents are more severe and thus more of these patients may require ICU admission 32 . Gram negative bacilli almost always affect patients who are elderly or suffering from underlying chronic illnesses 11, 26, 31, 32, [64] [65] [66] [67] . COAD was found to be the most common underlying disease in patients with pneumonia due to Gram negative bacteria 11 , and alcoholics are particularly prone to klebsiella pneumonia 50, 51 . Prior antibiotic therapy has been postulated as a predisposing factor but this remains unproved 23 . These organisms are usually sensitive to the third generation cephalosporins or the fluoroquinolones 64, 68 .
Haemophilus influenzae is mainly found in the elderly, those admitted from nursing homes, patients with COAD 26 , and alcoholics 50 . Where ampicillinresistant H. influenzae is common, a second generation cephalosporin such as cefuroxime may be prescribed 31 .
Pseudomonas aeruginosa is not a common pathogen and is usually restricted to patients with pre-existing lung problems 19 and the elderly, although it may be more common in certain regions 58 . Third generation cephalosporins with anti-pseudomonal activity, imipenem, or fluoroquinolones are the agents of choice in susceptible patients 29 .
Staphylococcus aureus is frequently associated with influenza 31, 47 , patients with underlying chronic respiratory or cardiovascular disease, and the elderly 26 . It is usually sensitive to cloxacillin. Only rarely is methicillin-resistant S. aureus the aetiologic agent in CAP, although these strains have been seen occasionally in intravenous drug addicts 69 .
M. tuberculosis can be important in regions where its incidence is high 20, 28, 32, 58 and may sometimes be encountered in Australia 26 .
Other organisms. SCAP may rarely be caused by acinetobacter 28, 32, 70 , which is usually fulminant and has a high mortality, fungi, or P. carinii even in the absence of immunodeficiency 32 . Viral pneumoniae are more common in those with preexisting chronic lung disease or cardiovascular disease 26 but its incidence is usually low in patients admitted into ICU because of SCAP.
Clinical and Haematological and Biochemical Features
Attempts to classify pneumonia by clinical presentation as "atypical" or "typical" pneumonia have been shown to lack predictive value 71 . It has been found that pneumococcal pneumonia is more frequently associated with a temperature over 39°C and chills at the onset of illness, thoracic pain, lobar consolidation, homogeneous infiltrate, and immature neutrophils of 5% or more 19, 38 . Klebsiella pneumonia is more commonly associated with lower platelet count (<150 x 109/l), and leucopenia (<4.0 x 109/l) 59 . Clinical features on the whole, however, are not sensitive or specific enough to predict the microbial aetiology 19, 29, 39 .
Radiological Features
The findings on chest X-ray, while not specific, may be suggestive of the likely aetiology. Levy et al 10 studied 116 patients with CAP and they classified lesions radiologically as follows: segmental or lobar alveolar densities (type I), patchy alveolar densities (type 2), mixed (alveolar/interstitial) opacities (type 3), and interstitial infiltrates (type 4). The results showed that alveolar densities (types 1, 2, and 3) were associated with a bacteriologic cause in 90% of cases. This was confirmed by another study 38 which showed that a lobar appearance on chest X-ray strongly indicated a pneumococcal pneumonia but was also seen in 2/27 patients with mycoplasma pneumonia; and an interstitial pattern was seen in half of the patients with mycoplasma pneumonia but in only two out of 127 cases with pneumococcal pneumonia. Consolidation with cavitation suggests a staphylococcal, TABLE 4 Microbial diagnosis in severe community-acquired pneumonia pseudomonal, klebsiella, or anaerobic aetiology. Diffuse bilateral infiltrates are common in viral or legionella pneumonia 27, 47 . Radiological parameters, if interpreted together with clinical and epidemiological data, may be valuable for predicting microbial aetiology 38 .
Microbiological Methods
The importance of making a microbiological diagnosis is illustrated by the findings of Leroy et al 22 : among eleven patients receiving an inadequate initial antimicrobial treatment, six were cured by a second therapy based on microbiologic results. The findings in some studies that a bacteriological diagnosis had no effect on patient outcome 10, 32 , was associated with poor outcome 19 , or that all lethal cases had a microbiologic diagnosis 9 should be interpreted with caution. Indeed the authors of these studies agreed that making a microbiologic diagnosis was important, even if invasive methods are required 9, 10, 32 . It is well proven that antibiotic administration before specimen sampling is significantly associated with undetermined aetiology and also that the success rate of pneumococcal antigen detection can be affected 13, 19, 23, 26, 34, 72 . It is always advisable to obtain samples for culture before starting antibiotics.
Expectorated Sputum
There are two problems with this time-honoured diagnostic method: difficulty in collecting sputum especially in the elderly patients 13 and the possibility of contamination of the specimen by oropharyngeal flora. Some authors have even suggested that sputum cultures should not be performed 29, 32, 73, 74 . On the other hand, there is evidence to show that Gram stain and culture of high quality sputum contribute significantly to microbiologic diagnosis, providing a diagnosis in 45-69%. Gram stain was found to be more sensitive than culture 10, 19, 23, 26, 47 . Taking all evidence into account, it seems reasonable to try to obtain sputum in every patient, and if collected, perform a Gram stain urgently. If the specimen is found to be of high quality, e.g. less than ten squamous cells and more than 25 leucocytes are present per low-power field, and with a predominant organism 10, 13, 26 , the information may be used to aid selection of empirical antibiotics and culture the specimen. Otherwise the specimen should be discarded. To improve the sensitivity and reliability of expectorated sputum culture, washing of sputum, homogenization by mucolytic agents and quantitative culture have been proposed [75] [76] [77] .
Blood Cultures
Although rarely contributing to diagnosis in patients without severe infection, blood culture is useful in patients with SCAP. As many as 15-50% of patients with SCAP caused by pneumococci 8, 10, 13, 19, 38, 78 and 20% of those caused by staphylococci 47 are bacteraemic. Blood culture should be performed in every patient with SCAP especially because the specificity is virtually 100%.
Cultures of Pleural Effusions
The yield from cultures of pleural effusions is usually less than one-third but is useful if it is positive because of its high specificity. It is also valuable for the exclusion of empyema 1, 19, 20, 22, 79 .
Fibreoptic Bronchoscopy
Since the clinical, laboratory, radiologic and noninvasive microbiologic parameters are not always effective in determining aetiology, invasive techniques may be justified. Fibreoptic bronchoscopy is an invasive, but simple and relatively safe technique with a low complication rate 9 . In a series of 24 patients, nearly 80% of the bronchoscopies were considered to be of value for the management of the patients by establishing or verifying an aetiologic diagnosis, or by preventing a severe bacterial pneumonia from being inadequately treated. Bronchoscopy also saved time by providing a rapid diagnosis in several patients, obviating the need for broad spectrum antibiotic treatment 72 .
Bronchoalveolar Lavage. To discriminate between contaminants and true pathogens, breakpoints at 104 or 105 CFU/ml are essential in semi-quantitative lavage cultures 11, 80 . Diagnostic sensitivity rates of between 80-90% can be achieved in patients with CAP 72, 80 , and in a recent study it provided a microbiologic diagnosis in 61% of patients 72 . To increase its specificity, which may be as low as 50% 9 , the lavage fluid has to be screened for quality: a percentage of squamous epithelial cells above 1% in bronchoalveolar lavage cytospin slides indicates oropharyngeal contamination and causes a high rate of false positives 81 . On the other hand, the presence of >3% neutrophils in lavage fluid and the demonstration of Gram-stained bacteria correlates with true positive lavage cultures 80, 81 . The method of Matthew et al 82 , using a sterile catheter inserted through a tracheal tube and blindly wedged in a peripheral bronchus (non-bronchoscopic alveolar lavage), seems to be a useful and safe technique for identification of the etiologic agent in lower respiratory tract infection 19 .
Protected Specimen Brushing. This technique is highly specific but its sensitivity is lower than broncheoalveolar lavage: it provides an aetiologic diagnosis in 33-34% of cases of SCAP only 9, 19 . Moine et al 19 postulated that the relatively poor result compared with nosocomial pneumonia may be due to administration of several doses of antibiotics before performing the technique, and the inoculum size of CAP probably is lower than that of nosocomial pneumonia. It has been suggested that a quantitative threshold of 10 3 or 10 4 CFU/ml should be used in CAP.
It is recommended that bronchoscopic methods, if available, should be performed under the following circumstances: 1. in patients with SCAP who do not have an aetiologic diagnosis established by noninvasive means 10,72 ; 2. in patients who fail to respond to empirical therapy; in these patients, bronchoscopy broadens the differential diagnosis beyond infectious processes 72,80 ; 3. in patients with severe pneumonia and antibiotic pretreatment in the foregoing weeks where the emergence of resistant organisms is likely 83 .
Other Invasive Techniques Transtracheal Aspiration. With this method, infralaryngeal secretions are collected by aspiration through a needle inserted through the cricothyroid membrane percutaneously. Contamination by passage through the upper respiratory tract is possible and the concordance rate with a confirmed diagnosis was found to be only 23% 19 . The method can be dangerous due to complications resulting from air leak 84, 85 . It is not recommended for routine use and definitely not in elderly and/or confused patients who cannot cooperate 9 .
Pulmonary Needle Aspiration. This is a highly specific technique which has yielded an aetiologic diagnosis in 53% of patients 32 . It is potentially hazardous especially in ventilated patients, however, and is not recommended for routine use. Pulmonary needle aspiration should not be attempted in patients with coagulopathy, bullous emphysema, severe hypoxaemia (PaO 2 <60 mmHg) despite oxygen therapy, or those patients requiring mechanical ventilatory support, or who are unable to cooperate 32 .
Immunological Methods
Detection of Pneumococcal Antigens. The diagnostic rate of pneumococcal pneumonia can be markedly increased by testing for pneumococcal polysaccharide capsular antigen in sputum, respiratory secretions, pleural fluid, urine or blood by countercurrent immunoelectrophoresis, latex agglutination or ELISA 1, 79 and the methods are especially valuable in patients with prior antibiotics treatment 26 .
Serology. Antibody detection assays are of great value in the diagnosis of pneumonia due to viruses, Mycoplasma spp., Chlamydia spp., and Legionella pneumophila. Serological diagnosis, however, is always delayed 9 .
Re-evaluation of Antimicrobial Therapy
Antimicrobial therapy should be re-evaluated when microbiologic diagnosis and sensitivity patterns are available 28 and should be changed to a more specific therapy in the light of laboratory and clinical parameters. With appropriate antimicrobial therapy, the patient can be expected to show improvement within 48 to 72 hours of commencement; therapy should not be changed in that period unless there is marked clinical deterioration or if an alternative aetiology is confirmed. Failure to respond may be indicated by persistence of fever and leucocytosis (both of them should subside by 72 to 96 hours), deterioration in oxygenation and ventilatory status or its failure to improve, deterioration in haemodynamic status or its failure to improve, spread of disease radiologically, and development of other organ failures. Failure to respond to initial therapy may be the result of inadequate antimicrobial selection, unusual pathogens, or because the patient is suffering from a disease other than pneumonia. Repetition of microbiologic workup including bronchoscopy should be performed and antimicrobial therapy should be modified according to any new information. Other investigations such as CT scan, lung scanning, and pulmonary angiography may be considered in individual cases for the detection of collections of pleural fluid and cavitation as well as the diagnosis of other pulmonary problems 10, 22, 29, 32, 72 .
Duration of Antimicrobial Therapy
There is little referenced information to support statements regarding the duration of treatment. When determining the duration of therapy, one should take into account the presence of significant underlying diseases, presence of bacteraemia, the severity of illness and the subsequent hospital course. The American Thoracic Society recommends that bacterial infections should be treated for seven to ten days' therapy; M. pneumoniae and C. pneumoniae may need 10 to 14 days; immunocompetent patients with Legionnaire's disease should receive antibiotics for 14 days and immunocompromised patients may require therapy for up to 21 days 29 .
EFFECTIVE SUPPORTIVE THERAPY Mechanical Ventilatory Support
As discussed above, a common cause of early death from SCAP is hypoxaemia and patients suffering from respiratory failure can benefit from mechanical ventilatory support. In selected patients who are haemodynamically stable and in whom tracheal intubation is not indicated for airway protection, noninvasive positive pressure ventilation by mask may be attempted in order to avoid problems associated with tracheal intubation 87, 88 . The risk of barotrauma with mechanical ventilation is high amongst patients with SCAP, especially in those with staphylococcal pneumonia 47 . This may be related to the high shearing pressures between atelectatic regions and the surrounding expanded lung 89 . Efforts should be made to keep the end-inspiratory plateau pressure below 30-35 cmH 2 O 90 to minimize the risk of barotrauma as well as microscopic lung damage. This may result in hypercapnia and acidosis in some patients although studies in patients with ARDS have shown that "permissive hypercapnia" appears to be less harmful for patients than the measures required to keep PaCO2 and pH "normal" [91] [92] [93] . Most patients require mechanical ventilatory support for one to two weeks, although it may be much longer 9, 11, 12, 22, 30, 33, 57 . In one series of 18 patients who still required ventilation after 14 days, 12 (67%) survived 33 . For patients requiring ventilation for over ten days, tracheostomy should be considered 94 .
Haemodynamic Support
Another important cause of death in patients with SCAP was septic shock. Adequate tissue perfusion should be maintained through the maintenance of adequate cardiac output and perfusion pressure by the use of vasoactive drugs and manipulation of preload. The principles of management are similar to those of other patients in septic shock 95 .
Physiotherapy
There is little place for physiotherapy in the acute management of pneumonia and it may merely exhaust an already septic and hypoxic patient. The exception is the patient with pneumonia complicating chronic bronchitis or bronchiectasis, or with lung suppuration. Patients intubated and requiring mechanical ventilatory support may benefit from physiotherapy 31 .
Other Supportive Therapy
Nutritional support, preferably through the enteral route, should be commenced early. Excessive caloric intake from carbohydrates may lead to increased carbon dioxide production and difficulties in weaning from mechanical ventilation 96, 97 . Substitution of fat for nonprotein calories may lower the respiratory quotient, reducing minute ventilation and ventilatory demand 98 . Bronchodilators may be helpful if there is bronchospasm. Stress ulceration prophylaxis, preferably with sucralfate 99 , should be considered in patients requiring mechanical ventilation.
CONCLUSION
Despite advances in antimicrobial and supportive therapy, the mortality of severe community-acquired pneumonia (SCAP) continues to be high, especially in patients requiring mechanical ventilatory support, patients in septic shock, and in bacteraemic patients. A review of all studies on SCAP published within the last 16 years showed that microbiologic diagnosis can be made in 50-80% of patients: the most common pathogen is S. pneumoniae, and other important pathogens included Legionella pneumophila and the enterobacteriaceae. Possible strategies to improve outcome include early identification of patients at risk using the American Thoracic Society guidelines and early admission to an intensive care unit, early institution of empirical antimicrobial therapy, reevaluation of antimicrobial therapy in cases of treatment failure, and appropriate supportive care. Patients over 60 and those with significant underlying diseases should receive special attention and be admitted to ICU early unless they are otherwise judged to be unsuitable. Exhaustive diagnostic procedures, including bronchoscopic methods if indicated and available, must be carried out as soon as possible and empirical antimicrobial therapy started immediately. Adequate supportive therapy and close monitoring of patients is equally important. The response of patients to antimicrobial therapy should be re-evaluated after 72 hours of therapy and treatment failures must be quickly dealt with. There is an urgent need to adopt a unified definition of SCAP and a unified system to quantify its severity in order to make comparisons valid and enable the evaluation of new therapies.
